Valuation: Haemonetics Corporation

Market Cap 4.93B 4.22B 3.96B 3.61B 6.82B 470B 6.89B 46.68B 18.17B 237B 18.5B 18.1B 785B P/E 2027 *
27.3x
P/E 2028 * 24x
Enterprise Value 5.59B 4.79B 4.49B 4.1B 7.74B 533B 7.81B 52.95B 20.61B 269B 20.99B 20.53B 890B EV / Sales 2027 *
3.95x
EV / Sales 2028 * 3.53x
Free-Float
98.74%
Yield 2027 *
0.92%
Yield 2028 * -
1 day-1.44%
1 week-1.37%
Current month+24.99%
1 month+33.80%
3 months+59.96%
6 months+71.79%
Current year+33.40%
1 week 106.49
Extreme 106.49
109.57
1 month 79.35
Extreme 79.35
109.57
Current year 51
Extreme 51
109.57
1 year 47.32
Extreme 47.315
109.57
3 years 47.32
Extreme 47.315
109.57
5 years 43.5
Extreme 43.5
109.57
10 years 32.76
Extreme 32.76
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 62 16/05/2016
Director/Board Member 71 18/10/2017
Date Insider Type Main position Quantity % Market Cap.
24/7/26 Free

Director

2,538 0.0056%
24/7/26 Free

Director

2,538 0.0056%
24/7/26 Free

Director

2,538 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-1.37%+93.59%+20.99% 4.93B
-1.05%+0.54%-12.57%+11.93% 201B
+0.82%-2.17%-0.10%+13.15% 117B
-0.09%+3.98%+13.82%+82.79% 62.6B
-0.12%-1.77%+29.62%+56.62% 52.49B
+0.11%+1.53%-1.86%-32.35% 51.69B
-0.79%-1.26%+16.59%-10.62% 33.65B
-1.23%+4.19% - - 31.27B
+1.22%-0.25%+43.93%-12.76% 24.52B
-0.94%+4.05%-2.80%+19.77% 24.05B
Average -0.38%+1.60%+20.03%+16.61% 60.28B
Weighted average by Cap. -0.34%+1.55%+3.18%+18.06%

Financials

2027 *2028 *
Net sales 1.41B 1.21B 1.14B 1.04B 1.96B 135B 1.98B 13.4B 5.22B 68.05B 5.31B 5.2B 225B 1.49B 1.28B 1.2B 1.09B 2.06B 142B 2.08B 14.1B 5.49B 71.62B 5.59B 5.47B 237B
Net income 177M 152M 142M 130M 246M 16.91B 248M 1.68B 654M 8.53B 666M 652M 28.26B 207M 178M 166M 152M 287M 19.76B 290M 1.96B 764M 9.97B 778M 761M 33.01B
Net Debt 662M 567M 532M 486M 916M 63.11B 925M 6.27B 2.44B 31.84B 2.49B 2.43B 105B 327M 280M 263M 240M 453M 31.19B 457M 3.1B 1.21B 15.73B 1.23B 1.2B 52.11B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
27/08/26 USD 106.76 -1.44% 145,650
25/08/26 USD 108.32 -0.07% 502,183
24/08/26 USD 108.40 -0.37% 641,055
21/08/26 USD 108.80 +0.54% 582,115
20/08/26 USD 108.22 -0.18% 891,223
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
108.32USD
Average target price
106.40USD
Spread / Average Target
-1.77%

Quarterly revenue - Rate of surprise